Tag

Tag: Novartis

29/08/2017 1 min

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

08/08/2017 2 mins

Update: The FDA Unanimously Recommends Approval of the First CAR-T Therapy

11/07/2017 3 mins

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

07/07/2017 1 min

More News! Biotechs Push G20 for Support in Battle against Antibiotic Resistance

26/06/2017 1 min

New Results from Novartis in the Race to Launch the First CAR-T

22/06/2017 1 min

Novartis Scores Major Phase III Win with New Cardiovascular Drug

20/06/2017 2 mins

Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials

19/06/2017 2 mins

Update: Novartis Takes on Blood Cancer with new Biosimilar Approval

15/06/2017 1 min

Novartis Announces New Data for its Psoriasis Blockbuster Cosentyx

15/06/2017 2 mins

UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech

02/05/2017 2 mins

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents

25/04/2017 2 mins

Novartis Negotiates its Way into the US Migraine Market

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.